Regulatory issues

New year, new attitudes in digital
New year, new attitudes in digital The real digital innovations in 2014 need to come in our attitudes, not our technologies
FDA releases draft social media guidance
FDA releases draft social media guidance Covers 'interactive promotional media', such as Facebook, Twitter and blogs
FDA releases draft social media guidance
FDA releases draft social media guidance Covers 'interactive promotional media', such as Facebook, Twitter and blogs
FDA takes 'tailored' approach to mobile app regulation
FDA takes 'tailored' approach to mobile app regulation Issues final guidance on smartphone and tablet computer technology
EMA prepares for digital signature introduction
EMA prepares for digital signature introduction From next month will accept digital signatures for certain procedures
Understanding the post-digital world
Understanding the post-digital world The ubiquity of digital demands that pharmaceutical companies focus more closely than ever on finding out what their customers want
Wanted: Social media innovation to detect AEs
Wanted: Social media innovation to detect AEs EU-pharma partnership seeks proposals on harnessing the power of the internet and social media to track adverse events
ABPI publishes updated guidance on pharmacovigilance and digital media
ABPI publishes updated guidance on pharmacovigilance and digital media In a guest blog, the ABPI's Esteban Herrero-Martinez explains what changes to European pharmacovigilance legislation mean for ABPI members
FDA says final mobile app guidance just weeks away
FDA says final mobile app guidance just weeks away And tells Congress only a fraction of mobile apps will need regulating
FDA smartphone regulation could stifle innovation
FDA smartphone regulation could stifle innovation US House Republicans issue warning on guidance and call for more information
Result pages: 1 | 2 (Next 10)